Frequently Asked Questions

UroLift®, a breakthrough minimally invasive treatment, generally takes less than an hour. This procedure offers multiple benefits for male patients with prostate enlargement.

After the UroLift® treatment, patients usually go home the same day, and experience minimal downtime, without a catheter and many patients experience symptom relief as early as 2 weeks post-op.

UroLift® has been found to be a safe and effective treatment for symptoms related to BPH, better than most traditional surgical options. Patients often report symptom relief better than reported with medications in a risk profile. 1

In a largely significant study on the UroLift® System, there were no newly reported instances of erectile dysfunction or ejaculatory dysfunction.4 Studies show that other BPH therapies such as TURP, laser, and even medication did not always produce such positive results.

Yes! UroLift® is covered by Medicare and also by many private insurance companies. You should contact your insurance provider for specific coverage information regarding this treatment.

UroLift® urethral implants are intended to be permanent. They are made from standard surgical implantable materials. If needed, your doctor is able to remove your implant by cutting the suture and retrieving the urethral end piece with a standard grasper. The capsular tab will remain in place inside the body.

The most common side effects reported by patients clinical studies were mild to moderate. They included pain or burning with urination, blood in the urine, pelvic pain, urgency with urination and/or the inability to control the urge to urinate. Most of these symptoms resolved themselves within two to four weeks after the UroLift® procedure.1

Request an appointment with Dr. Lotenfoe to discuss whether or not the UroLift® System is right for you. You can also visit the UroLift® website to view more frequently asked questions. https://www.urolift.com/patients/faqs